Skip to content

Sanomedics, Inc.: 10-Q filed 2011-08-16

What Sanomedics, Inc. reported in its quarterly report filed 2011-08-16 (fiscal Q2 2011): 29 published measures, 77 facts as tagged in accession 0001013762-11-002260.

This filing

Form
10-Q (quarterly report)
Filed
2011-08-16
Fiscal period
fiscal Q2 2011
Accession
0001013762-11-002260 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Sanomedics, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-06-30269,719USD
At 2010-12-31276,386USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-06-30-3,138,269USD
At 2010-12-31-2,409,875USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2011-06-3021,431USD
At 2010-12-312,837USD
At 2010-06-3026,181USD
At 2009-12-31779USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-385,941USD91
2011-01-01 to 2011-06-30-728,394USD181
2010-04-01 to 2010-06-30-330,665USD91
2010-01-01 to 2010-06-30-1,245,293USD181

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2011-01-01 to 2011-06-30-365,809USD181
2010-01-01 to 2010-06-30-413,318USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2011-01-01 to 2011-06-301,730USD181
2010-01-01 to 2010-06-307,045USD181

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2011-01-01 to 2011-06-30387,083USD181
2010-01-01 to 2010-06-30469,138USD181

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2011-01-01 to 2011-06-30-2,680USD181
2010-01-01 to 2010-06-30-30,418USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2011-06-30-4,558,670USD
At 2010-12-31-3,830,276USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-06-3023,934USD
At 2010-12-3124,201USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2010-01-01 to 2010-06-30734,750USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-340,920USD91
2011-01-01 to 2011-06-30-648,722USD181
2010-04-01 to 2010-06-30-313,763USD91
2010-01-01 to 2010-06-30-1,216,755USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-06-30199,138USD
At 2010-12-31203,361USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2011-04-01 to 2011-06-3045,021USD91
2011-01-01 to 2011-06-3079,672USD181
2010-04-01 to 2010-06-3016,902USD91
2010-01-01 to 2010-06-3028,538USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-06-301,949,063USD
At 2010-12-312,686,261USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2011-06-302,537USD
At 2010-12-317,371USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2011-04-01 to 2011-06-30341,563USD91
2011-01-01 to 2011-06-30656,405USD181
2010-04-01 to 2010-06-30324,690USD91
2010-01-01 to 2010-06-301,222,033USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2011-06-30175,170USD
At 2010-12-31193,153USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2011-04-01 to 2011-06-30643USD91
2011-01-01 to 2011-06-307,683USD181
2010-04-01 to 2010-06-3010,927USD91
2010-01-01 to 2010-06-305,278USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-04-01 to 2011-06-3067,709USD91
2011-01-01 to 2011-06-30135,879USD181
2010-04-01 to 2010-06-3050,802USD91
2010-01-01 to 2010-06-30110,990USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-06-3013,635,939shares
At 2010-12-3113,635,939shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-06-301,426,764USD
At 2010-12-311,426,764USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2011-06-3046,647USD
At 2010-12-3148,824USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-385,941USD91
2011-01-01 to 2011-06-30-728,394USD181
2010-04-01 to 2010-06-30-330,665USD91
2010-01-01 to 2010-06-30-1,245,293USD181

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2011-04-01 to 2011-06-30272,016USD91
2011-01-01 to 2011-06-30515,401USD181
2010-04-01 to 2010-06-30273,597USD91
2010-01-01 to 2010-06-301,110,638USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2011-01-01 to 2011-06-301,998USD181
2010-01-01 to 2010-06-30405USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2011-04-01 to 2011-06-30-45,021USD91
2011-01-01 to 2011-06-30-79,672USD181
2010-04-01 to 2010-06-30-16,902USD91
2010-01-01 to 2010-06-30-28,538USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-06-304,834USD181
2010-01-01 to 2010-06-30-10,430USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-06-3017,983USD181
2010-01-01 to 2010-06-30-79,632USD181

Inspect the source

Entity
Sanomedics, Inc. / CIK 0001501972
Captured
SEC response SHA-256
6c0af9720a10416680c6fc5e8d6f44722f1dfb1953be5b58d23cea65d053ff75

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001501972.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))